The clinical presentation of PIT1 positive pituitary neuroendocrine tumor immunonegative for growth hormone, prolactin, and thyroid stimulating hormone with analysis of clinical and immunostaining dissociation-Reference-Cited by-同舟云学术

The clinical presentation of PIT1 positive pituitary neuroendocrine tumor immunonegative for growth hormone, prolactin, and thyroid stimulating hormone with analysis of clinical and immunostaining dissociation

Published:2024-01 Issue: Volume:236 Page:108075
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Hong Sukwoo,Shinya Yuki,Trejo-Lopez Jorge A.,Gruber Lucinda M.,Erickson Dana,Bendok Bernard R.,Chaichana Kaisorn L.,Atkinson John L.,Marino Michael J.,Donaldson Angela M.,Stokken Janalee K.,Westphal Sydney A.,Chang Alice Y.,Samson Susan L.,Choby Garret W.,Van Gompel Jamie J.

Publisher

Elsevier BV

Subject

Neurology (clinical),General Medicine,Surgery

Reference16 articles.

1. WHO Classification of Tumours of Endocrine Organs;Lloyd;Int. Agency Res. Cancer,2017

2. The 2017 WHO classification of pituitary adenoma: overview and comments;Inoshita;Brain Tumor Pathol.,2018

3. Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ;Xekouki;Endocr. Relat. Cancer,2019

4. Pituitary tumors: genetic and molecular factors underlying pathogenesis and clinical behavior;Spada;Neuroendocrinology,2022

5. Utility of Pit-1 immunostaining in distinguishing pituitary adenomas of primitive differentiation from null cell adenomas;Lee;Endocr. Pathol.,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Mineral Preparation Dibeston: The Effect on the State of Excretory Kidney Function in Diabetes Mellitus;Archives of Pharmacy Practice;2024